CRESCENT BIOPHARMA, INC. Stock-Based Compensation
CRESCENT BIOPHARMA, INC. (CBIO) reported Stock-Based Compensation of $8.08 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-07-30
- CRESCENT BIOPHARMA, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $3.96M, a 25.75% decline year-over-year.
- CRESCENT BIOPHARMA, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $4.11M, a 234.66% increase year-over-year.
- CRESCENT BIOPHARMA, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $4.75M, a 318.43% increase year-over-year.
- CRESCENT BIOPHARMA, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $1.99M, a 74.50% increase year-over-year.
- CRESCENT BIOPHARMA, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $13.30M, a 183.13% increase from fiscal 2024.
- CRESCENT BIOPHARMA, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $4.70M, a 33.28% increase from fiscal 2023.
- CRESCENT BIOPHARMA, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $3.52M, a 8.64% decline from fiscal 2022.
- CRESCENT BIOPHARMA, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $3.86M, a 36.63% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 0 month | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $8.08M 10-Q · filed 2026-07-30 | $12.82M derived: sum of 3 quarters · filed 2026-07-30 | $14.81M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2026-03-31 | $4.11M 10-Q · filed 2026-04-29 | $8.86M derived: sum of 2 quarters · filed 2026-04-29 | $10.84M derived: sum of 3 quarters · filed 2026-04-29 | $16.18M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-12-31 | $4.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $6.73M derived: sum of 2 quarters · filed 2026-02-26 | $12.07M derived: sum of 3 quarters · filed 2026-07-30 | $13.30M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $1.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $7.33M derived: sum of 2 quarters · filed 2026-07-30 | $8.55M 10-Q · filed 2025-11-06 | $9.69M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-06-30 | $5.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $6.57M 10-Q · filed 2026-07-30 | $7.70M derived: sum of 3 quarters · filed 2026-07-30 | $8.84M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-03-31 | $1.23M 10-Q · filed 2026-04-29 | $405.43K 10-Q · filed 2025-05-14 | $2.36M derived: sum of 2 quarters · filed 2026-04-29 | $3.50M derived: sum of 3 quarters · filed 2026-04-29 | $4.71M derived: sum of 4 quarters · filed 2026-04-29 | |
| 2024-12-31 | $1.13M 10-K · filed 2026-02-26 | $2.27M derived: sum of 2 quarters · filed 2026-02-26 | $3.48M derived: sum of 3 quarters · filed 2026-02-26 | $4.70M 10-K · filed 2025-02-13 | ||
| 2024-09-30 | $69.00K 10-Q · filed 2025-11-06 | $1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $2.35M derived: sum of 2 quarters · filed 2024-11-13 | $3.54M 10-Q · filed 2024-11-13 | $4.45M derived: sum of 4 quarters · filed 2025-05-14 | |
| 2024-06-30 | $1.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $2.40M 10-Q · filed 2024-08-08 | $3.31M derived: sum of 3 quarters · filed 2025-05-14 | $4.20M derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2024-03-31 | $1.19M 10-Q · filed 2025-05-14 | $2.10M derived: sum of 2 quarters · filed 2025-05-14 | $2.99M derived: sum of 3 quarters · filed 2025-05-14 | $3.85M derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | $908.37K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $1.80M derived: sum of 2 quarters · filed 2025-02-13 | $2.65M derived: sum of 3 quarters · filed 2025-02-13 | $3.52M 10-K · filed 2025-02-13 | ||
| 2023-09-30 | $887.84K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $1.75M derived: sum of 2 quarters · filed 2024-11-13 | $2.62M 10-Q · filed 2024-11-13 | $3.52M derived: sum of 4 quarters · filed 2024-11-13 | ||
| 2023-06-30 | $858.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $1.73M 10-Q · filed 2024-08-08 | $2.63M derived: sum of 3 quarters · filed 2024-08-08 | $3.54M derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | $870.18K 10-Q · filed 2024-05-09 | $1.77M derived: sum of 2 quarters · filed 2024-05-09 | $2.68M derived: sum of 3 quarters · filed 2024-05-09 | $3.65M derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2022-12-31 | $899.20K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $1.81M derived: sum of 2 quarters · filed 2024-03-27 | $2.78M derived: sum of 3 quarters · filed 2024-03-27 | $3.86M 10-K · filed 2024-03-27 | ||
| 2022-09-30 | $913.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $1.88M derived: sum of 2 quarters · filed 2023-11-03 | $2.96M 10-Q · filed 2023-11-03 | $4.28M derived: sum of 4 quarters · filed 2024-03-27 | ||
| 2022-06-30 | $963.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $2.04M 10-Q · filed 2023-08-02 | $3.36M derived: sum of 3 quarters · filed 2024-03-27 | $4.96M derived: sum of 4 quarters · filed 2024-03-27 | ||
| 2022-03-31 | $1.08M 10-Q · filed 2023-05-03 | $2.40M derived: sum of 2 quarters · filed 2024-03-27 | $3.99M derived: sum of 3 quarters · filed 2024-03-27 | $5.55M derived: sum of 4 quarters · filed 2024-03-27 | ||
| 2021-12-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $2.91M derived: sum of 2 quarters · filed 2024-03-27 | $4.47M derived: sum of 3 quarters · filed 2024-03-27 | $6.09M 10-K · filed 2024-03-27 | ||
| 2021-09-30 | $1.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $3.15M derived: sum of 2 quarters · filed 2022-11-09 | $4.77M 10-Q · filed 2022-11-09 | $6.39M derived: sum of 4 quarters · filed 2023-03-29 | ||
| 2021-06-30 | $1.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $3.18M 10-Q · filed 2022-08-03 | $4.80M derived: sum of 3 quarters · filed 2023-03-29 | $6.49M derived: sum of 4 quarters · filed 2023-03-29 | ||
| 2021-03-31 | $1.61M 10-Q · filed 2022-04-28 | $3.24M derived: sum of 2 quarters · filed 2023-03-29 | $4.93M derived: sum of 3 quarters · filed 2023-03-29 | $6.69M derived: sum of 4 quarters · filed 2023-03-29 | ||
| 2020-12-31 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $3.32M derived: sum of 2 quarters · filed 2023-03-29 | $5.08M derived: sum of 3 quarters · filed 2023-03-29 | $6.90M 10-K · filed 2023-03-29 | ||
| 2020-09-30 | $1.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $3.45M derived: sum of 2 quarters · filed 2021-11-02 | $5.27M 10-Q · filed 2021-11-02 | $7.00M derived: sum of 4 quarters · filed 2022-03-03 | ||
| 2020-06-30 | $1.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $3.58M 10-Q · filed 2021-08-05 | $5.31M derived: sum of 3 quarters · filed 2022-03-03 | $6.90M derived: sum of 4 quarters · filed 2022-03-03 | ||
| 2020-03-31 | $1.82M 10-Q · filed 2021-05-03 | $3.55M derived: sum of 2 quarters · filed 2022-03-03 | $5.14M derived: sum of 3 quarters · filed 2022-03-03 | $6.65M derived: sum of 4 quarters · filed 2022-03-03 | ||
| 2019-12-31 | $1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $3.31M derived: sum of 2 quarters · filed 2022-03-03 | $4.83M derived: sum of 3 quarters · filed 2022-03-03 | $6.22M 10-K · filed 2022-03-03 | ||
| 2019-09-30 | $1.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $3.11M derived: sum of 2 quarters · filed 2020-11-06 | $4.49M 10-Q · filed 2020-11-06 | $5.64M derived: sum of 4 quarters · filed 2021-03-02 | ||
| 2019-06-30 | $1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $2.90M 10-Q · filed 2020-07-31 | $4.05M derived: sum of 3 quarters · filed 2021-03-02 | $5.22M derived: sum of 4 quarters · filed 2021-03-02 | ||
| 2019-03-31 | $1.38M 10-Q · filed 2020-05-01 | $2.53M derived: sum of 2 quarters · filed 2021-03-02 | $3.70M derived: sum of 3 quarters · filed 2021-03-02 | $4.85M derived: sum of 4 quarters · filed 2021-03-02 | ||
| 2018-12-31 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $2.32M derived: sum of 2 quarters · filed 2021-03-02 | $3.47M derived: sum of 3 quarters · filed 2021-03-02 | $4.59M 10-K · filed 2021-03-02 | ||
| 2018-09-30 | $1.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $2.32M derived: sum of 2 quarters · filed 2019-11-07 | $3.44M 10-Q · filed 2019-11-07 | $4.40M derived: sum of 4 quarters · filed 2020-02-28 | ||
| 2018-06-30 | $1.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $2.27M 10-Q · filed 2019-08-01 | $3.23M derived: sum of 3 quarters · filed 2020-02-28 | $4.19M derived: sum of 4 quarters · filed 2020-02-28 | ||
| 2018-03-31 | $1.12M 10-Q · filed 2019-05-02 | $2.08M derived: sum of 2 quarters · filed 2020-02-28 | $3.04M derived: sum of 3 quarters · filed 2020-02-28 | $4.03M derived: sum of 4 quarters · filed 2020-02-28 | ||
| 2017-12-31 | $964.50K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $1.93M derived: sum of 2 quarters · filed 2020-02-28 | $2.92M derived: sum of 3 quarters · filed 2020-02-28 | $3.76M 10-K · filed 2020-02-28 | ||
| 2017-09-30 | $962.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $1.95M derived: sum of 2 quarters · filed 2018-11-02 | $2.80M 10-Q · filed 2018-11-02 | $3.52M derived: sum of 4 quarters · filed 2019-03-06 | ||
| 2017-06-30 | $991.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $1.83M 10-Q · filed 2018-08-09 | $2.56M derived: sum of 3 quarters · filed 2019-03-06 | $3.30M derived: sum of 4 quarters · filed 2019-03-06 | ||
| 2017-03-31 | $842.85K 10-Q · filed 2018-05-03 | $1.57M derived: sum of 2 quarters · filed 2019-03-06 | $2.31M derived: sum of 3 quarters · filed 2019-03-06 | $3.08M derived: sum of 4 quarters · filed 2019-03-06 | ||
| 2016-12-31 | $726.12K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $1.47M derived: sum of 2 quarters · filed 2019-03-06 | $2.24M derived: sum of 3 quarters · filed 2019-03-06 | $2.96M 10-K · filed 2019-03-06 | ||
| 2016-09-30 | $739.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $1.51M derived: sum of 2 quarters · filed 2017-11-08 | $2.24M 10-Q · filed 2017-11-08 | |||
| 2016-06-30 | $771.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $1.50M 10-Q · filed 2017-08-03 | ||||
| 2016-03-31 | $727.55K 10-Q · filed 2017-05-08 | |||||
| 2015-12-31 | $2.32M 10-K · filed 2018-03-06 | |||||
| 2014-12-31 | $1.64M 10-K · filed 2017-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |